Signal transduction: Activation of the guanylate cyclase-cyclic guanosine-3'-5' monophosphate system by hormones and free radicals

American Journal of the Medical Sciences

Volumn 314, Issue 5, 1997, Pages 311-323

  Vesely, David L ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cyclic GMP; Free radicals; Guanylate cyclase; Hormones

Indexed keywords

CYCLIC GMP; FREE RADICAL; GUANYLATE CYCLASE; PROTEIN KINASE;

BLOOD PRESSURE MONITORING; CHEDIAK HIGASHI SYNDROME; CHEMOTAXIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; LYSOSOME; MEMBRANE BINDING; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030779789     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199711000-00008     Document Type: Review

References (135)

1. White AA, Aurbach GD. Detection of guanyl cyclase in mammalian tissues. Biochim Biophys Acta. 1969;191:686-97.
2. Hardman JG, Sutherland EW. Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J Biol Chem. 1969;244:6363-70.
3. Schultz G, Bohme E, Munske K. Guanyl cyclase. Determination of enzyme activity. Life Sci. 1969;8:1323-32.
4. Vesely DL. Testosterone, its precursors and metabolites enhance guanylate cyclase activity in the rat. Proc Natl Acad Sci U S A. 1979;76:3491-4.
5. DeRubertis FR, Craven PA. Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines. Science. 1976;193:897-9.
6. Vesely DL, Rovere LE, Levey GS. Activation of guanylate by streptozotocin and 1-methyl-1-nitrosourea. Cancer Res. 1977;37:28-31.
7. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res. 1977;3:23-35.
8. Mittal CK, Murad F. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: A physiological regulator of guanosine 3′,5′-monophosphate formation. Proc Natl Acad Sci U S A. 1977;74:4360-4.
9. Vesely DL, Watson B, Levey GS. Activation of liver guanylate cyclase by paraquat: Possible role of superoxide anion. J Pharmacol Exp Ther. 1979;209:162-4.
10. Vesely DL, Benson WR, Shenin EB, Levey GS. Two components of laetrile (mandelonitrile and cyanide) stimulate guanylate cyclase activity. Proc Soc Exp Biol Med. 1979;161:319-21.
11. Kimura H, Murad. Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem. 1974;249:6910-6.
12. Neer EJ, Sukiennik EA. Guanylate cyclase from the rat renal medulla, physical properties and comparison with adenylate cyclase. J Biol Chem. 1975;250:7905-9.
13. Chrisman TD, Garbers DL, Parks MA, Hardman JG. Characterization of particulate and soluble guanylate cyclases from rat lung. J Biol Chem. 1975;250:374-81.
14. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, et al. Molecular cloning of a new type of cell surface receptor: A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature. 1989;338:78-83.
15. DeJong HR. Properties of guanylate cyclase and levels of cyclic GMP in rat small intestinal villous and crypt cells. FEBS Lett. 1975;55:143-52.
16. Quill H, Weiser MW. Adenylate and guanylate cyclase activities and cellular differentiation in rat small intestine. Gastroenterology. 1975;69:470-8.
17. Craven PA, DeRubertis FR. Properties and subcellular distribution of guanylate cyclase activity in rat renal medulla: Correlation with tissue content of guanosine 3′,5′-monophosphate. Biochemistry. 1976;15:5131-7.
18. Wallach D, Pastan I. Stimulation of membranous guanylate cyclase by concentration of calcium that are in the physiological range. Biochem Biophys Res Commun. 1976;72: 859-65.
19. 2+ and other divalent cations on enzyme activity. Biochim Biophys Acta. 1979;566:171-82.
20. Rubin Y, Kessler-Icekson G, Navon G. The effect of furosemide on calcium ion concentrations in myocardial cells. Cell Calcium. 1995;18:135-9.
21. Vesely DL, Hill DE. Estrogens and progesterone increase fetal and maternal guanylate cyclase activity. Endocrinology. 1980;107:2104-9.
22. Vesely DL. Human and rat growth hormones enhance guanylate cyclase activity. Am J Physiol. 1981;240:E79-81.
23. Waldman SA, Rapoport RM, Murad F. Atrial natriuretic factor selectively activates membranous guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem. 1984;259:14332-4.
24. Vesely DL. Atrial Natriuretic Hormones. Englewood Cliffs: NJ; Prentice Hall; 1992:256.
25. Vesely DL. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Clin Exp Pharmacol Physiol. 1995;22:108-14.
26. Kano T, Miyachi T. Direct action of melatonin on testosterone and GMP production using rat testis tissue in vitro. Biochem Biophys Res Commun. 1976:72;969-75.
27. Vesely DL, Castro A, Levey GS. Decreased rat hepatic guanylate cyclase activity in streptozotocin-induced diabetes mellitus. Diabetes. 1977;26:308-13.
28. Vesely DL. On the mechanism of action of adrenocortical steroids: Cortisol and aldosterone enhance guanylate cyclase activity. J Pharmacol Exp Ther. 1980;214:561-6.
29. Vesely DL. Angiotensin II stimulates guanylate cyclase activity in aorta, heart, and kidney. Am J Physiol. 1981;240:E391-3.
30. Stuart CA, Vesely DL, Provow SA, Furnaletto RW. Cyclic nucleotides and somatomedin action in cartilage. Endocrinology. 1982;111:553-8.
31. Vesely DL, Meiners SE. Cimetedine partially blocks gastrin's activation of gastric mucosal guanylate cyclase. Endocrinology. 1983;112:1925-9.
32. Vesely DL, Juan D. Cation dependent vitamin D activation of human renal cortical guanylate cyclase. Am J Physiology 1984;246:E115-20.
33. Vesely DL. Cation-dependent prolactin activation of guanylate cyclase. Biochem Biophys Commun. 1984;123:1084-90.
34. Vesely Dl, Norris JS, Walters JM, Jespersen RR, Baeyens DA. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem Biophys Res Commun. 1987;148:1540-8.
35. Vesely DL. Cation-dependent gonadotropin releasing hormone activation of guanylate cyclase. Mol Cell Biochem 1985;66:145-9.
36. Howell Sl, Montague W. Regulation of guanylate cyclase in guinea-pig islets of langerhans. Biochem J. 1974; 142:379-84.
37. Scheving LA, Scheving LE, Tsai TH, Vesely DL. Epidermal growth factor enhances guanylate cyclase activity in vivo and in vitro. Endocrinology. 1985;116:332-6.
38. Vesely DL, Bayliss JM, Sallman AL. Human prepro atrial natriuretic factors 26-55, 56-92, and 104-123 increase renal guanylate cyclase activity. Biochem Biophys Res Commun. 1987;143:186-92.
39. Vesely DL, Chown J, Levey GS. Guanylate cyclase activity in fetal, neonatal, and adult rat heart. J Mol Cell Cardiol. 1976;8:909-13.
40. Vesely DL, Levey GS. Enhancement of human guanylate cyclase activity by chemical carcinogens. Proc Soc Exp Biol Med. 1977;155:301-4.
41. Vesely DL, Levey GS. Hydrazine activation of guanylate cyclase: Potential application to tobacco carcinogenesis. Biochem Biophys Res Commun. 1977;74:780-4.
42. Vesely DL, Levey GS. Inhibition of nitroso chemical carcinogen activation of rat hepatic guanylate cyclase by anticancer agents. Oncology. 1979;36:122-6.
43. Vesely DL, Graves WR, Lo TM, Fletcher MA, Levey GS. Isolation of a guanylate cyclase inhibitor from balsam pear Mormortica charantia abbreviata. Biochem Biophys Res Commun. 1977;77:1294-9.
44. Claflin AJ, Vesely DL, Hudson JL, Bagwell CB, Lehotay DC, Lo TM, et al. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear Mormortica charantia abbreviata. Proc Natl Acad Sci U S A. 1978;75:989-93.
45. Miki N, Kawabe Y, Kuriyama K. Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun. 1977;75:851-6.
46. Haddox MK, Stephenson JH, Moser ME, Goldberg ND. Oxidative-reductive modulation of guinea pig splenic cell guanylate cyclase activity. J Biol Chem. 1978;253:3143-52.
47. White AA, Crawford KM, Patt CS, Lad PJ. Activation of cytosolic guanylate cyclase from rat lung by incubation or by hydrogen peroxide. J Biol Chem. 1976;251:7304-12.
48. Ujiie K, Drewitt JG, Yuen PST, Star RA. Differential expression of mRNA for guanyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney. J Clin Invest. 1993;91:730-4.
49. Ujiie K, Hogarth L, Danziger R, Drewett JG, Yuen PS, Pang IH, et al. Homologous and heterologous desensitization of a guanyl-cyclase linked nitric oxide receptor in cultured rat medullary interstitial cells. J Pharmacol Exp Ther. 1994;270:761-7.
50. Furchgott RF. The discovery of endothelium-dependent relaxation. Circulation. 1993;87(suppl V):V3-8.
51. 2+ release channel in frog skeletal muscle. Am J Physiol. 1996;271:C810-8.
52. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-6.
53. Baxter JD, Wagner RL, Ribeiro RCJ, West BL, Apriletti JW, Fletterick RJ. Mechanisms of thyroid hormone receptor function: studies using x-ray crystallography and molecular biology (abstract). Proc 79th Meeting of Endocrine Society. 1997:15.
54. Mathews CK, Van Holde KE. Biochemistry. Menlo Park: CA; The Benjamin/Cumings Publishing Company; 1995: 133.
55. Finger TE, Bryant BP, Kalinoski DL, Teeter JH, Bottger B, Grosvenor W, et al. Differential localization of putative amino acid receptors in the taste buds of the channel catfish, Ictalurus punctatus. J Comp Neurol. 1996; 373:129-38.
56. Chervitz SA, Lin CM, Falke JJ. Transmembrane signaling by the aspartate receptor: Engineered disulfides reveal static regions of the subunit interface. Biochemistry. 1995;34:9722-33.
57. Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, et al. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J. 1989;8:1377-84.
58. Singh S, Lowe DG, Thorpe DS, Rodriguez H, Kuang WJ, Dangott LJ, et al. Membrane guanylate cyclase is a cell-surface receptor with homology to protein kinases. Nature. 1988;334:708-12.
59. Koesling D, Herz J, Gausephol H, Nirromand F, Hisch KD, Mulsch A, et al. The primary structure of the 70 kDa subunit of bovine cytosolic guanylate cyclase. FEBS Lett. 1988;239:29-34.
60. Nakane M, Saheki S, Kuno T, Isii K, Murad F. Molecular cloning of cDNA coding for 70 kilodalton subunit of cytosolic guanylate cyclase from rat lung. Biochem Biophys Res Commun. 1998;157:1139-47.
61. Thorpe DS, Garbers DL. The membrane form of guanylate cyclase: homology with a subunit of the cytoplasmic form of the enzyme. J Biol Chem. 1989;264:6545-9.
62. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, et al. Atrial natriuretic peptide clearance receptor: complete sequence and functional expression of cDNA clones. J Biol Chem. 1988;263:9395-401.
63. Maack T, Suzuki M, Almeida FA, Nussen Weig D, Scarborough RM, McEnroe GA, et al. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987;238:675-8.
64. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, et al. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell. 1989;58:1155-62.
65. Koller KJ, Lowe DJ, Bennett GL, Minamino N, Kangawa K, Matsuo H, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-3.
66. Schulz S, Green CK, Yuen PST, Garbers DL. Guanylyl cyclase is a heat stable enterotoxin receptor. Cell. 1990; 63:941-8.
67. DeSauvage FJ, Camerato TR, Goeddel DV. Primary structure and functional expression of the human receptor for Escherichia coli heat stable exterotoxin. J Biol Chem. 1991;266:17912-8.
68. Chinkers M, Garbers DL. The protein kinase domain of the ANP receptor is required for signaling. Science. 1989;245:1392-4.
69. Fesenko EE, Kolesnikov SS, Lyubarsky AL. Induction by cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segment. Nature. 1985;313:310-3.
70. Haynes LW, Yau K-W. Cyclic GMP-sensitive conductance in outer segment membrane of catfish cones. Nature. 1985;317:64-6.
71. Cobbs Wh, Barkdoll AE III, Pugh EN Jr. Cyclic GMP increases photocurrent and light sensitivity of retinal cones. Nature. 1985;317:64-6.
72. Nakamura T, Gold GH. A cyclic nucleotide-gated conductance in olfactory receptor cilia. Nature. 1987;325:442-4.
73. Carpietier JL, Gorden P, Amherdt M, Van Obberghen E, Kahn CR, Orci L. Insulin binding to cultured human lymphocytes. Initial localization and fate of hormone determined by quantitative electron microscopic autoradiography. J Clin Invest. 1978;61:1057-70.
74. 125I-Labeled human epidermal growth factor. Binding, internalization and degradation in human flbroblasts. J Cell Biol. 1976;71:159-71.
75. EL Etreby MF, Mahrous AT. Immunocytochemical technique for detection of prolactin (PRL) and growth hormone (GH) in hyperplastic and neoplastic lesions of dog prostate and mammary gland. 1979;64:279-86.
76. Goldfine ID, Smith GJ, Young KY, Jones AL. Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: Evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A. 1977;74:1368-72.
77. Franceschi RT, Simpson RU, DeLuca HF. Binding proteins for Vitamin D metabolites: Serum carriers and intracellular receptors. Arch Biochem Biophys. 1981;210:1-13.
78. Vesely DL. Bee venom enhances guanylate cyclase activity. Science. 1981;213:359-60.
79. Vesely DL, Cantell K. Human interferon enhances guanylate cyclase activity. Biochem Biophys Res Commun. 1980;96:574-9.
80. Rudland PS, Gospodarowicz D, Seifert W. Activation of guanyl cyclase and intracellular cyclic GMP by fibroblast growth factor. Nature. 1974;250:741-2, 773-4.
81. Asakawa T, Scheinbaum I, Ho R. Stimulation of guanylate cyclase activity by several fatty acids. Biochem Biophys Res Commun. 1976;73:141-8.
82. Wallach D, Pasten I. Stimulation of guanylate cyclase of fibroblasts by free fatty acids. J Biol Chem. 1976;251:5802-9.
83. Vesely DL. Cation-dependent substance P activation of the enzyme guanylate cyclase. Biochem Biophys Res Commun. 1985;128:141-7.
84. Vesely DL. B complex vitamins activate rat guanylate cyclase and increase cyclic GMP levels. Eur J Clin Invest. 1985;15:258-62.
85. Kurtz A. Adenosine stimulates guanylate cyclase activity in smooth muscle cells. J Biol Chem. 1987;262:6292-300.
86. Vesely DL. Direct effect of glibeclamide on guanylate cyclase activity in the rat in vitro. Diabetologia. 1982;22:269-72.
87. Vesely DL. The comparative effects of tolbutamide and the non-hypoglycemic analog carboxytolbutamide on guanylate cyclase activity. Horm Metab Res. 1986;18:10-3.
88. Lehotay DC, Levey GS, Rogerson B, Ruiz E, Yourist JE, Miller KD. Activation of guanylate cyclase by alpha toxins from krait and cobra venom. Toxicon. 1980;18:185-90.
89. Vesely DL. Gila monster and Mexican beaded lizard venoms enhance guanylate cyclase activity. Res Commun Chem Pathol Pharm. 1982;36:119-27.
90. Field M, Graf LH, Laird WJ, Smith PL. Heat-stable enterotoxin of Escherichia coli: In vitro effects on guanylate cyclase activity, cyclic GMP accumulation and ion transport in small intestine. Proc Natl Acad Sci U S A. 1978;75:2800-4.
91. Vesely DL, Straub KD, Nolan CM, Rolfe RD, Finegold SM, Monson TP. Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity. Infect Immun. 1981;33:285-91.
92. Ichibara K, Lamer J, Kimura H, Murad F. Activation of liver guanylate cyclase by bile salts and contaminants in crude secretin and pancreozymin preparations. Biochim Biophys Acta. 1977;481:734-40.
93. Thompson WJ, Williams RH, Little SA. Activation of guanyl cyclase and adenyl cyclase by secretin. Biochim Biophys Acta. 1977;481:734-40.
94. Amer MS. Cyclic guanosine 3′, 5′-monophosphate and gallbladder contraction. Gastroenterology. 1974;67:333-7.
95. Vesely DL. Phencyclidine stimulates guanylate cyclase activity. Biochem Biophys Res Commun. 1979;88:1244-8.
96. Vesely DL. Bromocriptine enhances guanylate cyclase activity. Endocrinology. 1981;109:1284-6.
97. Ohlstein EH, Wood KS, Ignarro LJ. Purification and properties of heme-deficient hepatic cytosolic guanylate cyclase: Effects of heme and other factors on enzyme activation by NO, NO-heme, and protoporphyrin DC. Arch Biochem Biophys. 1982;218:187-98.
98. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H. Guanylate cyclase: Activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res. 1978;9:145-58.
99. Ignarro LJ, Gross RA, Gross DM. Inhibition of mammalian cytosolic guanylate cyclase activity by adenosine 5′-tetraphosphate, guanosine 5′-tetraphosphate and other nucleotides. J Cyclic Nucleotide Res. 1976;2:337-46.
100. Whitfield JF, MacManus JP, Franks DJ, Gillan DJ, Youdale T. The possible mediation by cyclic AMP of the stimulation of thymocyte proliferation by cyclic GMP. Proc Soc Exp Biol Med. 1971;37:453-8.
101. Kram R, Tompkins GM. Pleiotypic control of cyclic AMP interaction with cyclic GMP and possible role of microtubules. Proc Natl Acad Sci U S A. 1973;70:1659-63.
102. Paulus H, Sarker H. Control of transcription in Bacillus brevis by small molecules. Basic Life Sci. 1974;3:21-34.
103. Varrone S, Dilauro R, Macchia V. Stimulation of polypeptide synthesis by cyclic 3′,5′-guanosine monophosphate. Arch Biochem Biophys. 1973;157:334-8.
104. Vesely DL, Lehotay DC, Levey GS. Effect of ethanol on myocardial guanylate and adenylate cyclase activity and on cyclic GMP and AMP levels. J Stud Alcohol. 1978;39:842-7.
105. Vesely DL, Levey GS. Saccharin inhibits guanylate cyclase activity: Potential relationship to carcinogenesis. Biochem Biophys Res Commun. 1978;81:1384-9.
106. Duda T, Sharma RK. Regulation of guanylate cyclase by atrial natriuretic factor and protein kinase C. Mol Cell Biochem. 1990;93:179-84.
107. Hamet P, Tremblay J, Pang SC, Garcia R, Thibault G, Gutkowska J, et al. Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun. 1984;123:515-27.
108. Ohlstein EH, Berkowitz BA. Cyclic guanosine mpnophosphate mediates vascular relaxation induced by atrial natriuretic factor. Hypertension. 1985;7:306-10.
109. Baeyens DA, Walters JM, Vesely DL. Atrial natriuretic factor increases the magnitude of duodenal spontaneous phasic contractions. Biochem Biophys Res Commun. 1988;155:1437-43.
110. Gill GN, McCune RW. Guanosine 3′,5′-monophosphate dependent protein kinase. Curr Top Cell Regul. 1979;15:1-45.
111. Wolfe L, Corbin JD, Francis SH. Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J Biol Chem. 1989;264:7734-41.
112. Lincoln TM, Thompson M, Cornwell TL. Purification and characterization of two forms of cyclic GMP-dependent protein kinase from bovine aorta. J Biol Chem. 1988; 263:17263-637.
113. Hoffman F, Dostmann W, Keilbach A, Landgraf W, Ruth P. Structure and physiological role of cGMP-dependent protein kinase. Biochim Biophys Acta. 1992;1135:51-60.
114. Takio K, Smith SB, Walsh KA, Krebs EG, Titani K. Amino acid sequence around a "hinge" region and its "autophosphorylation" site in bovine lung cGMP-dependent protein kinase. J Biol Chem. 1983;258:5531-6.
115. Lincoln TM, Cornwell TD. Intracellular cyclic GMP proteins. FASEB J. 1993;7:328-38.
116. DeJonge HR. Cyclic GMP-dependent protein kinase in intestinal brush borders. Adv Cyclic Nucleotide Res. 1981; 14:315-23.
117. Landgraf W, Hoffman F. The amino terminus regulates binding to and activation of cGMP-dependent protein kinase. Eur J Biochem. 1989;181:643-50.
118. Light DB, Corbin JD, Stanton BA. Dual ion-channel regulation by cyclic GMP and cyclic GMP-dependent protein kinase. Nature. 1990;344:336-9.
119. Foster JL, Guttmann J, Rosen OM. Autophosphorylation of GMP-dependent protein kinase. J Biol Chem. 1981; 256:5029-36.
120. Landgraf W, Hullin R, Gobel C, Hoffmann F. Phosphorylation of cGMP-dependent protein kinase increases the affinity for cyclic AMP. Eur J Biochem. 1986;154:113-7.
121. Yamazaki A, Sen I, Bitensky MW, Casnellie JE, Greengard P. Cyclic GMP-specific, high affinity, non-catalytic binding sites on light-activated phosphodiesterase. J Biol Chem. 1980;255:11619-24.
122. Whalin ME, Strada SJ, Thompson WJ. Purification and partial characterization of a membrane-associated type-II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain. Biochim Biophys Acta. 1988;972:79-94.
123. Thomas MK, Francis SH, Corbin JD. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J Biol Chem. 1990;265:14964-70.
124. Manganiello VC, Smith CG, Degerman E, Belfrage P. Cyclic GMP-inhibited cyclic nucleotide phosphodiesterases. In: Beavo J, Housley MD; eds. Cyclic Nucleotide Phosphodiesterases: Structure, Regulation, and Drug Action. New York: Wiley; 1990:87-116.
125. Sonnenberg WK, Beavo J. Cyclic GMP and regulation of cyclic nucleotide hydrolases. Adv Pharmacol. 1994;26:87-114.
126. Whalin ME, Scammell JG, Strada SJ, Thompson WJ. Phosphodiesterase II, the cGMP activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells. Mol Pharmacol. 1991;39:711-7.
127. Harrison SA, Rifsnyder DH, Gallis B, Cadd GG, Beavo JA. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol. 1986;29:506-14.
128. Huang DL, Ives HE, Cogan MG. In vivo evidence that cGMP is the second messenger for atrial natriuretic factor. Proc Natl Acad Sci U S A. 1986;83:8015-8.
129. Zeidel ML, Silva P, Brenner BM, Seifter JL. cGMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol. 1987;252:F551-9.
130. Kurtz A, Della Bruna RD, Pfeilschiffer J, Taugner R, Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci U S A. 1986;83:4769-73.
131. 2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ Res. 1993;73:1128-37.
132. Poulos JE, Gower WR Jr, Sullebarger JT, Fontanet HL, Vesely DL. Congestive heart failure: Increased atrial natriuretic peptide gene expression in rat stomach antrum. Cardiovasc Res. 1996;32:909-19.
133. Ignarro LF, Colombo C. Enzyme release from polymorphonuclear leukocyte lysosomes: Regulation by autonomic drugs and cyclic nucleotides. Science. 1973;180:1181-3.
134. Estensen RD, Hill HR, Quie PG, Hogan N, Goldberg ND. Cyclic GMP and cell movement. Nature. 1973;245:458-60.
135. Boxer LA, Rister M, Allen JM, Baehner RL. Improvement of Chediak-Higashi (C-H) leukocyte (PMN) function by cyclic guanosine monophosphide (GMP) (abstract). Pediatr Res. 1976;10:396.